14-day Premium Trial Subscription Try For FreeTry Free
$11.42
-0.340 (-2.89%)
At Close: Apr 24, 2024
Forecast Earnings Fundamentals Insider Trading Signals Historical Prices Predictions News Profile

Range Low Price High Price Comment
30 days $11.21 $12.67 Wednesday, 24th Apr 2024 DVAX stock ended at $11.42. This is 2.89% less than the trading day before Tuesday, 23rd Apr 2024. During the day the stock fluctuated 3.35% from a day low at $11.35 to a day high of $11.73.
90 days $11.21 $14.10
52 weeks $10.20 $15.15

Historical Dynavax Technologies Corporation prices

Date Open High Low Close Volume
Apr 24, 2024 $11.70 $11.73 $11.35 $11.42 1 200 730
Apr 23, 2024 $11.87 $12.08 $11.70 $11.76 1 334 151
Apr 22, 2024 $11.83 $12.01 $11.72 $11.84 1 895 589
Apr 19, 2024 $11.30 $11.85 $11.25 $11.80 6 819 083
Apr 18, 2024 $11.32 $11.37 $11.21 $11.34 2 102 601
Apr 17, 2024 $11.56 $11.56 $11.34 $11.43 2 395 834
Apr 16, 2024 $11.61 $11.62 $11.47 $11.49 1 785 590
Apr 15, 2024 $11.72 $11.86 $11.56 $11.69 1 875 434
Apr 12, 2024 $12.01 $12.02 $11.76 $11.84 1 941 135
Apr 11, 2024 $12.03 $12.11 $11.88 $12.01 1 154 746
Apr 10, 2024 $11.91 $12.03 $11.80 $11.95 1 808 372
Apr 09, 2024 $11.98 $12.06 $11.95 $12.02 1 402 351
Apr 08, 2024 $12.03 $12.11 $11.90 $12.05 859 316
Apr 05, 2024 $12.07 $12.17 $11.92 $12.05 1 099 479
Apr 04, 2024 $12.17 $12.39 $12.04 $12.08 1 336 345
Apr 03, 2024 $12.24 $12.33 $12.12 $12.19 1 248 772
Apr 02, 2024 $12.50 $12.50 $12.09 $12.31 2 316 985
Apr 01, 2024 $12.40 $12.67 $12.25 $12.58 1 451 176
Mar 28, 2024 $12.39 $12.52 $12.34 $12.41 1 332 443
Mar 27, 2024 $12.48 $12.48 $12.34 $12.41 762 469
Mar 26, 2024 $12.59 $12.64 $12.35 $12.37 1 064 916
Mar 25, 2024 $12.26 $12.53 $12.26 $12.50 987 600
Mar 22, 2024 $12.21 $12.37 $12.14 $12.29 929 257
Mar 21, 2024 $12.20 $12.38 $12.15 $12.16 1 263 163
Mar 20, 2024 $11.97 $12.15 $11.92 $12.10 1 867 233
Click to get the best stock tips daily for free!

About Dynavax Technologies Corporation

Dynavax Technologies Dynavax Technologies Corporation, a biopharmaceutical company, focuses on developing and commercializing novel vaccines in the United States. The company markets HEPLISAV-B, a hepatitis B vaccine for prevention of infection caused by all known subtypes of hepatitis B virus in age 18 years and older in the United States and Europe. It also manufactures and sells CpG 1018, the adjuvant used in HEPLISAV-B. Dynavax Technologies Corporation has a coll... DVAX Profile

Golden Star

Ticker Date Change Price
MLI Apr 19 10.86% $52.28
LPLA Apr 19 0.743% $262.59
DOOR Apr 18 0.160% $131.39
LNG Apr 17 0.389% $156.81
FCN Apr 16 2.95% $207.62
ELV Apr 16 5.28% $506.97
DXC Apr 08 0.767% $20.87
AKR Apr 05 5.63% $16.53
ITCI Apr 05 6.84% $68.44
SARK Mar 28 13.80% $26.88
Unlock

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT